Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 851 - 900 out of 11,555

Document Document Title
WO/2013/088959A1
This organic electroluminescent element, which has at least one light emitting layer between a positive electrode and a negative electrode, contains a hexadentate coordinated orthometalated iridium complex represented by general formula ...  
WO/2013/043787A3
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/087689A1
The present invention relates to iron (III) complexes of the formula Fe(L)x(Y)3-x, where the ligand L has the formula (I). Such complexes are especially suitable as a catalyst for two-component polyurethane compositions. The invention al...  
WO/2013/086804A1
Disclosed are a quad-nuclear platinum complex having a crisscross structure, a preparation method thereof, and application thereof in preparing a drug for treating human cancer. The complex is prepared through self-assembly of a single t...  
WO/2013/083058A1
Disclosed are a platinum type compound with leaving group being hydroxy acid derivative containing amino group or alkyl amino, pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition containing...  
WO/2013/043783A3
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/043912A3
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/083921A1
A medical or therapeutic application of a composite material of ruthenium with a nitrosyl ligand. Application for a medical or therapeutic treatment of a composite material of ruthenium with a nitrosyl ligand irradiated in a spectral ran...  
WO/2013/079820A1
The invention relates to a method for metathesizing identical or different linear alpha olefins into linear internal olefins having excellent selectivity, using a ruthenium complex comprising an asymmetrical N-heterocyclic carbine as a c...  
WO/2013/076197A1
Disclosed are novel dye compounds, method of making them, and their use in photoelectric conversion devices, especially in dye-sensitized solar cells. The dye compounds are organometallic compounds of formula ML1L2, wherein L1 and L2 ind...  
WO/2013/077654A1
The present invention relates to an iridium (III) complex having an amidine derivative as an organic ligand, and an organic electroluminescent device having properties such as improved light emitting efficiency, driving voltage, service ...  
WO/2013/077344A1
This organic electroluminescent element comprises a substrate, a pair of electrodes arranged on said substrate and consisting of a positive electrode and a negative electrode, and one or more organic layers arranged between said electrod...  
WO/2013/073243A1
A novel compound represented by general formula (1), a support supporting this novel compound, and a photoelectric transduction element using this support. (In the formula, Y is an optionally substituted hydrocarbon group having 1-20 car...  
WO/2013/071724A1
Disclosed is a baicalin metal complex, having a molecular formula of (C2H17O11)xM(H2O)y, wherein M is Cu(II) or zinc (II), x is 1, and y is 2; or M is Fe(III), x is 2, and y is 0; or M is La(III) or Y(III), x is 3, and y is 0. The prepar...  
WO/2013/069545A1
Provided is a complex compound which is composed of a compound represented by formula (I), a metal and at least one kind of ion that is selected from the group consisting of ions obtained by adding one or more protons to amines, ammonium...  
WO/2013/068389A1
The invention relates to a process for the preparation of formic acid by reaction of carbon dioxide with hydrogen.  
WO/2013/070725A1
The current application describes tungsten oxo alkylidene complexes for olefin metathesis.  
WO/2013/061850A1
Provided is an organic electroluminescence element having at least one light-emitting layer between the anode and the cathode, and containing a hexadentate ligand type ortho-metal iridium complex represented by general formula (I) below....  
WO/2013/063504A1
The subject invention concerns a compound and compositions having activity as an inhibitor of Stat3 protein and methods of using the compound and compositions. In one embodiment, a compound of the invention has the structure shown in for...  
WO/2013/061724A1
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/058087A1
Provided is an organic electroluminescent element, wherein an organic layer consisting of one or more layers and having at least one light-emitting layer is interposed between a positive electrode and a negative electrode. The light-emit...  
WO/2013/033018A3
The present invention discloses a class of organometallic catalysts for both hydrogenation and water oxidation. The synthesis and the use of these catalysts for hydrogenation, hydrogen production and water oxidation reactions is also dis...  
WO/2013/058451A1
The present invention relates to a ruthenium compound that includes a specific ligand structure of 1-ethyl-1,4-cyclohexadienedione, 1,3-butadiene, or isoprene, and has excellent thermal stability, vaporizing properties and step coverage,...  
WO/2013/056400A1
Novel catalyst compositions based on Ruthenium- or Osmium-based complex catalysts and specific co-catalyst and a process for selectively hydrogenating nitrile rubbers in the presence of such catalyst compositions are disclosed.  
WO/2013/058844A1
A system and method for systematically generating potential metal-organic framework (MOFs) structures given an input library of building blocks is provided herein. One or more material properties of the potential MOFs are evaluated using...  
WO/2013/058845A1
A system and method for systematically generating potential metal-organic framework (MOFs) structures given an input library of building blocks is provided herein. One or more material properties of the potential MOFs are evaluated using...  
WO/2013/054863A1
The present invention is a raw material for chemical vapor deposition, which can be used for the production of a platinum thin film or a platinum compound thin film by a chemical vapor deposition method, and which comprises an organic pl...  
WO/2013/055644A2
A method for preparing a ruthenium carbene complex precursor includes reacting a ruthenium refinery salt with a hydrogen halide to form a ruthenium intermediate, and reacting the ruthenium intermediate with an L-type ligand to form the r...  
WO/2013/016237A3
Disclosed are precursors having a pyrrolecarbaldiminates ligand and methods of synthesizing the same. The pyrrolecarbaldiminates ligand may be substituted.  
WO/2013/051670A1
Provided is a technique making it easy to form a high-quality cobalt-based film which has a low melting point and is liquid at about 40°C, is unlikely to solidify and create a blockage midway in piping, and enables a stable supply of ra...  
WO/2013/016229A3
Disclosed are precursors having a pyrrolecarbaldiminates ligand and methods of synthesizing the same. The pyrrolecarbaldiminates ligand may be substituted.  
WO/2013/045876A1
Cis and trans ruthenium complexes that can be used as catalysts for ring opening metathesis polymerisation (ROMP) are described. The complexes are generally square pyramidal in nature, having two anionic ligands X. Corresponding cationic...  
WO/2013/046108A1
The subject of the present invention are novel metal complexes defined by Formula (1): The present invention also relates to methods of producing said novel metal complexes defined by Formula (1) as well as their uses.  
WO/2013/049019A1
Antenna ligands for use in dye-sensitized solar cells are described. The antenna ligands consist of a bidentate or tridentate heteroaromatic metal-chelating group having at least one independently selected antenna group substituted there...  
WO/2013/047517A1
An iridium complex which has a phenylpyridine bidentate ligand that has a group represented by general formula (A). In general formula (A), X represents a cyano group or a halogenated alkyl group; L represents a single bond or a divalent...  
WO/2012/155004A3
A composition including a Rh or Ru metalloinsertor complex specifically targets mismatch repair (MMR)-deficient cells. Selective cytotoxicity is induced in MMR-deficient cells upon uptake of the inventive metalloinsertor complexes.  
WO/2013/043785A2
A composition contains (A) a hydrosi!ylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per moiecuie, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosiiyiaiion r...  
WO/2012/116234A3
Methods of making bis-tridentate carbene complexes of ruthenium and osmium are provided. The use of DMSO solvates of ruthenium(II) and osmium(II) halide salts provides good yields of the corresponding complexes. These materials may be us...  
WO/2012/173413A3
The present invention relates to a carbon monoxide/olefin copolymerizing catalyst, and to a suspension-polymerization production process using same. More particularly, the present invention relates to a compound expressed by chemical for...  
WO/2013/042446A1
This organic electroluminescent element has, on a substrate (1), a positive electrode (2) and a negative electrode (8) that are paired electrodes, and at least one light-emitting layer (5). The light-emitting layer (5) contains at least ...  
WO/2013/043912A2
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/043783A2
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/042626A1
A transition metal complex represented by general formula (1) [wherein: M represents a transition metal element; K and L represent a monodentate or bidentate ligand; m and o represent an integer of 0-5; n represents an integer of 1-3; X,...  
WO/2013/043846A1
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/041014A1
Disclosed are a platinum compound having amino- or alkylamino-containing succinic acid derivatives as a leaving group, or pharmaceutically acceptable salts thereof, preparation method therefor, and medicinal compositions containing the c...  
WO/2013/043787A2
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...  
WO/2013/038134A1
There is described a complex of formula I: in which, R1, R2, R3, R4, R5 and R6 are each, hydrogen, alkyl CI to 20 alkenyl CI to 20, aryl, alkyl(ci t0 20)aryl, alkenyl(Ci t0 20>aryl, heteroaryl, etc.; R7, R8 and R9 are each, hydrogen or a...  
WO/2013/040276A1
Multi-metallic organometallic complexes that allow performance of olefin based reaction and in particular polymerization of olefins to produce polyolefin polymers, and related methods and systems are described.  
WO/2012/116231A3
Novel phosphorescent tetradentate platinum (II) compounds comprising a twisted aryl group are provided. Also provided are novel phosphorescent tetradentate platinum (II) compounds comprising an imidazo[1,2-f]phenanthridine moiety. The co...  
WO/2013/038395A1
The family of ruthenium compounds that is subject of the present patent was found to exhibit great potential as pharmaceutical agents for the treatment of cancer condition. In fact, the present compounds which structure is based on piano...  

Matches 851 - 900 out of 11,555